<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37748514</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-4687</ISSN><JournalIssue CitedMedium="Internet"><Volume>623</Volume><Issue>7985</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Distinguishing features of long COVID identified through immune profiling.</ArticleTitle><Pagination><StartPage>139</StartPage><EndPage>148</EndPage><MedlinePgn>139-148</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41586-023-06651-y</ELocationID><Abstract><AbstractText>Post-acute infection syndromes may develop after acute viral disease<sup>1</sup>. Infection with SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long COVID. Individuals with long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions<sup>2-4</sup>. However, the biological processes that are associated with the development and persistence of these symptoms are unclear. Here 275 individuals with or without long COVID were enrolled in a cross-sectional study that included multidimensional immune phenotyping and unbiased machine learning methods to identify biological features associated with long COVID. Marked differences were noted in circulating myeloid and lymphocyte populations relative to the matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with long COVID. Furthermore, higher antibody responses directed against non-SARS-CoV-2 viral pathogens were observed among individuals with long COVID, particularly Epstein-Barr virus. Levels of soluble immune mediators and hormones varied among groups, with cortisol levels being lower among participants with long COVID. Integration of immune phenotyping data into unbiased machine learning models identified the key features that are most strongly associated with long COVID status. Collectively, these findings may help to guide future studies into the pathobiology of long COVID and help with developing relevant biomarkers.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Klein</LastName><ForeName>Jon</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-3552-7684</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wood</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jaycox</LastName><ForeName>Jillian R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dhodapkar</LastName><ForeName>Rahul M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-2014-7515</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, USC Keck School of Medicine, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lu</LastName><ForeName>Peiwen</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-6118-872X</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gehlhausen</LastName><ForeName>Jeff R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Dermatology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tabachnikova</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Kerrie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabacof</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Amyn A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva Monteiro</LastName><ForeName>Valter</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0003-1785-6713</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Julio</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8212-7440</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamath</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>SerImmune, Goleta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Minlu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2347-0569</Identifier><AffiliationInfo><Affiliation>SerImmune, Goleta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhal</LastName><ForeName>Abhilash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>SerImmune, Goleta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ott</LastName><ForeName>Isabel M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valle</LastName><ForeName>Gabrielee</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;a-Hern&#xe1;ndez</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Tianyang</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9251-8592</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharjee</LastName><ForeName>Bornali</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0801-1543</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Takehiro</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1061-356X</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucas</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4590-2756</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5448-5865</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCarthy</LastName><ForeName>Dayna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Breyman</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosto-Mancuso</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yile</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7761-3361</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perotti</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akduman</LastName><ForeName>Koray</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzeng</LastName><ForeName>Tiffany J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geraghty</LastName><ForeName>Anna C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monje</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3547-237X</Identifier><AffiliationInfo><Affiliation>Department of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yildirim</LastName><ForeName>Inci</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-8631-0020</Identifier><AffiliationInfo><Affiliation>Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics (Infectious Diseases), Yale New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shon</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>SerImmune, Goleta, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medzhitov</LastName><ForeName>Ruslan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7021-2012</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lutchmansingh</LastName><ForeName>Denyse</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Possick</LastName><ForeName>Jennifer D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaminski</LastName><ForeName>Naftali</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5917-4601</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omer</LastName><ForeName>Saad B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0002-5383-3474</Identifier><AffiliationInfo><Affiliation>Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine (Infectious Diseases), Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-2046-127X</Identifier><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guan</LastName><ForeName>Leying</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dela Cruz</LastName><ForeName>Charles S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-5258-1797</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine (Pulmonary, Critical Care and Sleep Medicine), Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Dijk</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3911-9925</Identifier><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA. david.vandijk@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, Yale University, New Haven, CT, USA. david.vandijk@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine (Cardiology), Yale School of Medicine, New Haven, CT, USA. david.vandijk@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ring</LastName><ForeName>Aaron M</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-3699-2446</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. aaron.ring@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA. aaron.ring@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putrino</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2232-3324</Identifier><AffiliationInfo><Affiliation>Abilities Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA. david.putrino@mountsinai.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, NY, USA. david.putrino@mountsinai.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasaki</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7824-9856</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA. akiko.iwasaki@yale.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI157488</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM143072</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 FD005938</GrantID><Acronym>FD</Acronym><Agency>FDA HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001863</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2022 Aug 10:2022.08.09.22278592. doi: 10.1101/2022.08.09.22278592</RefSource><PMID Version="1">35982667</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="Y">Herpesvirus 4, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="Y">Hydrocortisone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016130" MajorTopicYN="N">Immunophenotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="Y">Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022423" MajorTopicYN="Y">Myeloid Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>In the past three years, H.M.K. received expenses and/or personal fees from UnitedHealth, Element Science, Eyedentifeye and F-Prime; he is a co-founder of Refactor Health and HugoHealth; and is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare &amp; Medicaid Services and through Yale University from the Food and Drug Administration, Johnson &amp; Johnson, Google and Pfizer. N.K. is a scientific founder at Thyron; served as a consultant to Boehringer Ingelheim, Pliant, Astra Zeneca, RohBar, Veracyte, Galapagos, Fibrogen and Thyron over the past 3 years; reports equity in Pliant and Thyron; and acknowledges grants from Veracyte, Boehringer Ingelheim and BMS. A.I. co-founded and consults for RIGImmune, Xanadu Bio and PanV; consults for Paratus Sciences and InvisiShield Technologies; and is a member of the Board of Directors of Roche Holding. A.M.R. and Y.D. are listed as inventors on a patent describing the REAP technology. A.M.R. is the founder and director of Seranova Bio. A.M.R. and Y.D. hold equity in Seranova Bio. The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>19</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37748514</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pii">10.1038/s41586-023-06651-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Choutka, J., Jansari, V., Hornig, M. &amp; Iwasaki, A. Unexplained post-acute infection syndromes. Nat. Med.28, 911&#x2013;923 (2022). 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai, T. et al. Development of a definition of postacute sequelae of SARS-CoV-2 Infection. JAMA329, 1934&#x2013;1946 (2023). 10.1001/jama.2023.8823</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med.27, 601&#x2013;615 (2021). 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen, M. et al. Characterising long COVID: a living systematic review. BMJ Glob. Health6, e005427 (2021). 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann, A. et al. Long-lasting severe immune dysfunction in Ebola virus disease survivors. Nat. Commun.11, 3730 (2020). 10.1038/s41467-020-17489-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17489-7</ArticleId><ArticleId IdType="pmc">PMC7381622</ArticleId><ArticleId IdType="pubmed">32709840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie, I. et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. Brit. Med. J.333, 575 (2006). 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Paix&#xe3;o, E. S. et al. Chikungunya chronic disease: a systematic review and meta-analysis. Trans. R. Soc. Trop. Med. Hyg.112, 301&#x2013;316 (2018). 10.1093/trstmh/try063</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/try063</ArticleId><ArticleId IdType="pubmed">30007303</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel, H., Sander, B. &amp; Nelder, M. P. Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect. Dis.15, 951&#x2013;959 (2015). 10.1016/S1473-3099(15)00134-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)00134-6</ArticleId><ArticleId IdType="pubmed">26163373</ArticleId></ArticleIdList></Reference><Reference><Citation>Trojan, D. A. &amp; Cashman, N. R. Post-poliomyelitis syndrome. Muscle Nerve31, 6&#x2013;19 (2005). 10.1002/mus.20259</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20259</ArticleId><ArticleId IdType="pubmed">15599928</ArticleId></ArticleIdList></Reference><Reference><Citation>Gowers, W. R. A post-graduate lecture on the nervous sequelae of influenza. Lancet142, 73&#x2013;76 (1893).10.1016/S0140-6736(00)65088-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)65088-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Althus, J. Influenza: its Pathology, Symptoms, Complications, and Sequels its Origin and Mode of Spreading and its Diagnosis, Prognosis, and Treatment (Longmans, 1892).</Citation></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol.21, 133&#x2013;146 (2023). 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, E., Du, H. &amp; Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis.20, 533&#x2013;534 (2020). 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature584, 463&#x2013;469 (2020). 10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas, C. et al. Delayed production of neutralizing antibodies correlates with fatal COVID-19. Nat. Med.27, 1178&#x2013;1186 (2021). 10.1038/s41591-021-01355-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01355-0</ArticleId><ArticleId IdType="pmc">PMC8785364</ArticleId><ArticleId IdType="pubmed">33953384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature595, 283&#x2013;288 (2021). 10.1038/s41586-021-03631-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew, D. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science369, eabc8511 (2020). 10.1126/science.abc8511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Y. et al. Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell183, 1479&#x2013;1495 (2020). 10.1016/j.cell.2020.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med.26, 1017&#x2013;1032 (2020). 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty, S. E. et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ373, n1098 (2021). 10.1136/bmj.n1098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>DeVries, A., Shambhu, S., Sloop, S. &amp; Overhage, J. M. One-year adverse outcomes among US adults with post-COVID-19 condition vs those without COVID-19 in a large commercial insurance database. JAMA Health Forum4, e230010 (2023). 10.1001/jamahealthforum.2023.0010</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2023.0010</ArticleId><ArticleId IdType="pmc">PMC9984976</ArticleId><ArticleId IdType="pubmed">36867420</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis, A. et al. Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. J. R. Soc. Med.116, 97&#x2013;112 (2023). 10.1177/01410768231154703</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768231154703</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly, Z., Xie, Y. &amp; Bowe, B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature594, 259&#x2013;264 (2021). 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E., Bowe, B. &amp; Al-Aly, Z. Long-term cardiovascular outcomes of COVID-19. Nat. Med.28, 583&#x2013;590 (2022). 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, E., Xie, Y. &amp; Al-Aly, Z. Long-term neurologic outcomes of COVID-19. Nat. Med.28, 2406&#x2013;2415 (2022). 10.1038/s41591-022-02001-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof, L. et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am. J. Phys. Med. Rehabil.101, 48&#x2013;52 (2022). 10.1097/PHM.0000000000001910</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C. et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis.226, 1593&#x2013;1607 (2022). 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering, A. V., van Zon, S. K. R., Olde Hartman, T. C., Rosmalen, J. G. M. &amp; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet Lond. Engl.400, 452&#x2013;461 (2022).10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Poh, C. M. et al. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat. Commun.11, 2806 (2020). 10.1038/s41467-020-16638-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16638-2</ArticleId><ArticleId IdType="pmc">PMC7264175</ArticleId><ArticleId IdType="pubmed">32483236</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. et al. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients. Cell. Mol. Immunol.17, 1095&#x2013;1097 (2020). 10.1038/s41423-020-00523-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00523-5</ArticleId><ArticleId IdType="pmc">PMC7475724</ArticleId><ArticleId IdType="pubmed">32895485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat, G. et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J. Transl. Autoimmun.4, 100100 (2021). 10.1016/j.jtauto.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski, C. et al. Long COVID: association of functional autoantibodies against G-protein-coupled receptors with an impaired retinal microcirculation. Int. J. Mol. Sci.23, 7209 (2022). 10.3390/ijms23137209</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23137209</ArticleId><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamath, K. et al. Antibody epitope repertoire analysis enables rapid antigen discovery and multiplex serology. Sci. Rep.10, 5294 (2020). 10.1038/s41598-020-62256-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62256-9</ArticleId><ArticleId IdType="pmc">PMC7093460</ArticleId><ArticleId IdType="pubmed">32210339</ArticleId></ArticleIdList></Reference><Reference><Citation>Fafi&#x2010;Kremer, S. et al. Long&#x2010;term shedding of infectious Epstein&#x2010;Barr virus after infectious mononucleosis. J. Infect. Dis.191, 985&#x2013;989 (2005). 10.1086/428097</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/428097</ArticleId><ArticleId IdType="pubmed">15717276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon, C. L. et al. Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection. J. Exp. Med.214, 651&#x2013;667 (2017). 10.1084/jem.20160758</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160758</ArticleId><ArticleId IdType="pmc">PMC5339671</ArticleId><ArticleId IdType="pubmed">28130404</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff, M. C. et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat. Commun.14, 4201 (2023). 10.1038/s41467-023-40012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40012-7</ArticleId><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J. &amp; Boyton, R. J. The immunology of long COVID. Nat. Rev. Immunol.10.1038/s41577-023-00904-7 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J. et al. Multimodal molecular imaging reveals tissue-based T cell activation and viral RNA persistence for up to 2 years following COVID-19. Preprint at medRxiv10.1101/2023.07.27.23293177 (2023).</Citation></Reference><Reference><Citation>Narasimhan, P. B., Marcovecchio, P., Hamers, A. A. J. &amp; Hedrick, C. C. Nonclassical monocytes in health and disease. Annu. Rev. Immunol.37, 439&#x2013;456 (2019). 10.1146/annurev-immunol-042617-053119</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042617-053119</ArticleId><ArticleId IdType="pubmed">31026415</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad, M., Sathe, P., Helft, J., Miller, J. &amp; Mortha, A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol.31, 563&#x2013;604 (2013). 10.1146/annurev-immunol-020711-074950</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-020711-074950</ArticleId><ArticleId IdType="pmc">PMC3853342</ArticleId><ArticleId IdType="pubmed">23516985</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina, Y. et al. Deep phenotyping of neurologic postacute sequelae of SARS-CoV-2 infection. Neurol. Neuroimmunol. Neuroinflammation10, e200097 (2023).10.1212/NXI.0000000000200097</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200097</ArticleId><ArticleId IdType="pmc">PMC10162706</ArticleId><ArticleId IdType="pubmed">37147136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos, M., Paiva, B., Montero-Mateo, R., Garcia, N. &amp; Zabaleta, A. Epstein-Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol.12, 656797 (2021). 10.3389/fimmu.2021.656797</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank, Z. et al. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin. Infect. Dis.76, e487&#x2013;e490 (2023). 10.1093/cid/ciac722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature612, 758&#x2013;763 (2022). 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut71, 226&#x2013;229 (2022). 10.1136/gutjnl-2021-324280</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow, M. K.-S. et al. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin. Endocrinol.63, 197&#x2013;202 (2005).10.1111/j.1365-2265.2005.02325.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell185, 881&#x2013;895 (2022). 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye, E. S., Pearce, S. H., Krone, N. P. &amp; K&#xe4;mpe, O. Adrenal insufficiency. Lancet397, 613&#x2013;629 (2021). 10.1016/S0140-6736(21)00136-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00136-7</ArticleId><ArticleId IdType="pubmed">33484633</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso, M. J. et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J. Clin. Invest.133, e163669 (2023). 10.1172/JCI163669</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold, J. E., Okyay, R. A., Licht, W. E. &amp; Hurley, D. J. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens10, 763 (2021). 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Public Health Surveillance for COVID-19: Interim Guidance (WHO, 2022).</Citation></Reference><Reference><Citation>Lucas, C. et al. Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature600, 523&#x2013;529 (2021). 10.1038/s41586-021-04085-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04085-y</ArticleId><ArticleId IdType="pmc">PMC9348899</ArticleId><ArticleId IdType="pubmed">34634791</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp, L. B., LaRocca, N. G., Muir-Nash, J. &amp; Steinberg, A. D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol.46, 1121&#x2013;1123 (1989). 10.1001/archneur.1989.00520460115022</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotler, J., Holtzman, C., Dudun, C. &amp; Jason, L. A. A brief questionnaire to assess post-exertional malaise. Diagnostics8, 66 (2018). 10.3390/diagnostics8030066</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics8030066</ArticleId><ArticleId IdType="pmc">PMC6165517</ArticleId><ArticleId IdType="pubmed">30208578</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenton, C. The MRC breathlessness scale. Occup. Med.58, 226&#x2013;227 (2008).10.1093/occmed/kqm162</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqm162</ArticleId><ArticleId IdType="pubmed">18441368</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson, G. L., Connors, E. J., Marsh, J. &amp; Terry, D. P. Examining normative reference values and item-level symptom endorsement for the quality of life in neurological disorders (Neuro-QoLTM) v2.0 cognitive function-short form. Arch. Clin. Neuropsychol.36, 126&#x2013;134 (2021). 10.1093/arclin/acaa044</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acaa044</ArticleId><ArticleId IdType="pubmed">32851403</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman, M. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res.20, 1727&#x2013;1736 (2011). 10.1007/s11136-011-9903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer, R. L., Kroenke, K., Williams, J. B. W. &amp; L&#xf6;we, B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med.166, 1092&#x2013;1097 (2006). 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke, K., Spitzer, R. L. &amp; Williams, J. B. W. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med. Care41, 1284&#x2013;1292 (2003). 10.1097/01.MLR.0000093487.78664.3C</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000093487.78664.3C</ArticleId><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder, E., Cai, B., DeMuro, C., Morrison, M. F. &amp; Ball, W. A new single-item sleep quality scale: results of psychometric evaluation in patients with chronic primary insomnia and depression. J. Clin. Sleep Med.14, 1849&#x2013;1857 (2018). 10.5664/jcsm.7478</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.7478</ArticleId><ArticleId IdType="pmc">PMC6223557</ArticleId><ArticleId IdType="pubmed">30373688</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris, P. A. et al. The REDCap consortium: building an international community of software platform partners. J. Biomed. Inform.95, 103208 (2019). 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris, P. A. et al. Research electronic data capture (REDCap)&#x2014;a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform.42, 377&#x2013;381 (2009). 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Oksanen, J. et al. vegan: Community Ecology Package. R package version 2.6-4 (2022).</Citation></Reference><Reference><Citation>Niesters, H. G. et al. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J. Clin. Microbiol.38, 712&#x2013;715 (2000). 10.1128/JCM.38.2.712-715.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.38.2.712-715.2000</ArticleId><ArticleId IdType="pmc">PMC86184</ArticleId><ArticleId IdType="pubmed">10655372</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes, W. A., Kamath, K., Waitz, R., Daugherty, P. S. &amp; Shon, J. C. Protein-based immunome wide association studies (PIWAS) for the discovery of significant disease-associated antigens. Front. Immunol.12, 625311 (2021). 10.3389/fimmu.2021.625311</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.625311</ArticleId><ArticleId IdType="pmc">PMC8110919</ArticleId><ArticleId IdType="pubmed">33986742</ArticleId></ArticleIdList></Reference><Reference><Citation>Tukey, J. W. Exploratory Data Analysis (Addison-Wesley, 1977).</Citation></Reference><Reference><Citation>Tibshirani, R. &amp; Hastie, T. Outlier sums for differential gene expression analysis. Biostatistics8, 2&#x2013;8 (2007). 10.1093/biostatistics/kxl005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/kxl005</ArticleId><ArticleId IdType="pubmed">16702229</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantazes, R. J. et al. Identification of disease-specific motifs in the antibody specificity repertoire via next-generation sequencing. Sci. Rep.6, 30312 (2016). 10.1038/srep30312</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep30312</ArticleId><ArticleId IdType="pmc">PMC4969583</ArticleId><ArticleId IdType="pubmed">27481573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, E. Y. et al. High-throughput identification of autoantibodies that target the human exoproteome. Cell Rep. Methods2, 100172 (2022). 10.1016/j.crmeth.2022.100172</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crmeth.2022.100172</ArticleId><ArticleId IdType="pmc">PMC8967185</ArticleId><ArticleId IdType="pubmed">35360706</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, M. D., McCarthy, D. J. &amp; Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics26, 139&#x2013;140 (2010). 10.1093/bioinformatics/btp616</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, 2013).</Citation></Reference><Reference><Citation>Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2009).</Citation></Reference><Reference><Citation>Bolstad, B. M., Irizarry, R. A., &#xc5;strand, M. &amp; Speed, T. P. A comparison of normalization methods for high densityoligonucleotide array data based on variance and bias. Bioinformatics19, 185&#x2013;193 (2003). 10.1093/bioinformatics/19.2.185</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/19.2.185</ArticleId><ArticleId IdType="pubmed">12538238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale, D. &amp; Shapley, L. S. College admissions and the stability of marriage. Am. Math. Mon.69, 9&#x2013;15 (1962).10.1080/00029890.1962.11989827</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00029890.1962.11989827</ArticleId></ArticleIdList></Reference><Reference><Citation>Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol.37, 38&#x2013;44 (2019).10.1038/nbt.4314</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4314</ArticleId><ArticleId IdType="pubmed">30531897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Z. Introduction to machine learning: k-nearest neighbors. Ann. Transl. Med.4, 218&#x2013;218 (2016). 10.21037/atm.2016.03.37</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2016.03.37</ArticleId><ArticleId IdType="pmc">PMC4916348</ArticleId><ArticleId IdType="pubmed">27386492</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform.12, 77 (2011).10.1186/1471-2105-12-77</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-77</ArticleId><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLong, E. R., DeLong, D. M. &amp; Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics44, 837&#x2013;845 (1988). 10.2307/2531595</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2531595</ArticleId><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Z., Eils, R. &amp; Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics32, 2847&#x2013;2849 (2016). 10.1093/bioinformatics/btw313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig C. fpc: Flexible procedures for clustering. R package Version 2.1-10 (2015).</Citation></Reference><Reference><Citation>Hothorn, T., Hornik, K., van de Wiel, M. A. &amp; Zeileis, A. Implementing a class of permutation tests: the coin package. J. Stat. Softw.28, 1&#x2013;23 (2008). 10.18637/jss.v028.i08</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v028.i08</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>